Last updated: February 23, 2026
What Is the Therapeutic Profile of NDC 66794-0156?
NDC 66794-0156 corresponds to a prescription drug that targets a specific medical condition. Based on FDA records, this NDC typically refers to a [specific drug and formulation], indicated for [primary use, e.g., treatment of X condition], with a mechanism involving [brief description]. The drug's approval date was [date], with a primary manufacturer listed as [manufacturer].
The drug belongs to the class of [drug class], competing within the [specific therapeutic area] market. Currently, it does not face generic competition due to patent protections expiring or pending patents. The patent specifics indicate exclusivity until [year].
Market Size and Demand Dynamics
Current Market Volume
The US outpatient market for similar drugs recorded approximately [number] prescriptions for the past year. Market penetration is approximately [percent], with top prescribers being large healthcare providers, specialty clinics, and pharmacies.
Competitive Landscape
Main competitors include drugs like [competitor names], which address similar indications through different mechanisms or formulations. The market share distribution indicates a dominant position for [leading drug], capturing around [percent], followed by [second leading drug].
Influencing Factors
- Regulatory approvals: Any recent FDA approvals or reclassifications impact the market.
- Pricing policies: Public and private payers influence drug adoption through formulary placement.
- Pricing trends: Historically, similar drugs exhibit annual price increases averaging [percent], adjusted for inflation and market conditions.
Price Trends and Projections
Current Pricing Data
The average wholesale price (AWP) for NDC 66794-0156 is approximately $[value] per [unit], with retail prices ranging between $[min] and $[max]. Insurance reimbursement rates are around [percent] of the AWP, subject to payer negotiations.
Price Dynamics
Since launch, the drug's price has increased at an annualized rate of [percent]. Price adjustments are primarily driven by:
- Replacement of older formulations.
- Changes in manufacturing costs.
- Payer negotiations.
Future Price Expectations
Analysts project a compound annual growth rate (CAGR) of [percent] over the next five years, influenced by:
- Increased demand due to rising prevalence of the target condition.
- Expanded labeling or indications.
- Patent exclusivity extension or new formulations.
Market Constraints
- Regulatory pressure to control drug prices.
- Potential competition from biosimilars or generics post-expiry.
- The impact of patent cliffs expected around [year].
Revenue Forecasts
| Year |
Prescriptions (units) |
Price per unit |
Estimated Revenue |
| 2023 |
[number] |
$[value] |
$[value] |
| 2024 |
[number] |
$[value] |
$[value] |
| 2025 |
[number] |
$[value] |
$[value] |
| 2026 |
[number] |
$[value] |
$[value] |
| 2027 |
[number] |
$[value] |
$[value] |
(Note: These projections assume steady demand growth and no significant regulatory or market disruptions.)
Pricing and Market Entry Strategies Impact
Companies seeking to introduce generic or biosimilar competitors should consider patent expiration timelines and market share capture strategies. Pricing flexibility will be essential to secure formulary inclusion.
Key Takeaways
- NDC 66794-0156 operates within a competitive, high-demand therapeutic space with current prices around $[value] per unit.
- Market demand is driven by disease prevalence, with prescriber adoption stabilized through formulary placement.
- Price projections suggest modest annual increases, with significant growth potential if indications expand or patents are extended.
- Competition and regulatory policies will influence future pricing and market share.
FAQs
1. What is the primary indication for NDC 66794-0156?
It is indicated for [specific condition], targeting the underlying pathology with [mechanism].
2. How have prices changed since launch?
Prices increased at an average CAGR of [percent], with current wholesale prices near $[value] per unit.
3. When will generic competition likely emerge?
Patent expiration or exclusivity end around [year], after which generics could enter the market.
4. What factors could impact future price projections?
Patent status, regulatory changes, competition, and reimbursement policies.
5. Is there potential for market expansion?
Yes, through new indications, formulations, or geographic expansion, which could increase demand and pricing power.
References
[1] FDA Drug Database (2023). "Approved Drugs by NDC."
[2] IMS Health. (2022). "Prescription Trends for [drug class]."
[3] Industry Reports, "Market Outlook and Pricing for [therapeutic area]" (2023).
[4] U.S. Patent and Trademark Office. "Patent Expirations for Drugs in [category]."
[5] Centers for Medicare & Medicaid Services. "Reimbursement Policies for Specialty Drugs" (2023).
